Metabolism-related enzyme alterations identified by proteomic analysis in human renal cell carcinoma

por Lu, Zejun, Yao, Yuqin, Song, Qi, Yang, Jinliang, Zhao, Xiangfei, Yang, Ping, Kang, Jingbo
Publicado en Onco Targets Ther (2016)

Discovery of human lactate dehydrogenase A (LDHA) inhibitors as anticancer agents to inhibit the proliferation of MG-63 osteosarcoma cells

por Fang, Aiping, Zhang, Qi, Fan, Haibo, Zhou, Yaying, Yao, Yuqin, Zhang, Yue, Huang, Xiaojun
Publicado en Medchemcomm (2017)

Establishment and characterization of intraperitoneal xenograft models by co-injection of human tumor cells and extracellular matrix gel

por YAO, YUQIN, ZHOU, YONGJUN, SU, XIAOLAN, DAI, LEI, YU, LIN, DENG, HONGXIN, GOU, LANTU, YANG, JINLIANG
Publicado en Oncol Lett (2015)

Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)

por Tang, Sumin, Yin, Yuan, Shen, Chaoyong, Chen, Jiaju, Yin, Xiaonan, Zhang, Bo, Yao, Yuqin, Yang, Jinliang, Chen, Zhixin
Publicado en World J Surg Oncol (2017)

Multi‐technical analysis on the antioxidative capacity and total phenol contents of 94 traditional Chinese dietary medicinal herbs

por He, Fangting, Chen, Jiayi, Dong, Ke, Leng, Yun, Xu, Jiayi, Hu, Pengwei, Yao, Yuqin, Xiong, Jingyuan, Pei, Xiaofang
Publicado en Food Sci Nutr (2018)

High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma

por Zhou, Shijie, Wang, Ping, Su, Xiaolan, Chen, Jingxia, Chen, Hongfen, Yang, Hanbing, Fang, Aiping, Xie, Linshen, Yao, Yuqin, Yang, Jinliang
Publicado en PLoS One (2017)

Correction: High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma

por Zhou, Shijie, Wang, Ping, Su, Xiaolan, Chen, Jingxia, Chen, Hongfen, Yang, Hanbing, Fang, Aiping, Xie, Linshen, Yao, Yuqin, Yang, Jinliang
Publicado en PLoS One (2018)

Tumor suppressor role of miR-876-5p in gastric cancer

por Zhao, Hongwei, Zheng, Yuzhu, You, Jia, Xiong, Jingyuan, Ying, Shi, Xie, Linshen, Song, Xuejiao, Yao, Yuqin, Jin, Zhaohui, Zhang, Chaoxiong
Publicado en Oncol Lett (2020)

The pharmacodynamic and differential gene expression analysis of PPAR α/δ agonist GFT505 in CDAHFD-induced NASH model

por Liu, Linfu, Liu, Chuang, Zhao, Manyu, Zhang, Qianru, Lu, Ying, Liu, Ping, Yang, Hua, Yang, Jinliang, Chen, Xiaoxin, Yao, Yuqin
Publicado en PLoS One (2020)

Isoalantolactone inhibits pancreatic cancer proliferation by regulation of PI3K and Wnt signal pathway

por Zhang, Chaoxiong, Huang, Lei, Xiong, Jingyuan, Xie, Linshen, Ying, Shi, Jia, You, Yao, Yuqin, Song, Xuejiao, Zeng, Zhenguo, Yuan, Jialing
Publicado en PLoS One (2021)

Comparative RNA-sequencing profiled the differential gene expression of liver in response to acetyl-CoA carboxylase inhibitor GS-0976 in a mouse model of NASH

por Lu, Ying, Su, Xiaolan, Zhao, Manyu, Zhang, Qianru, Liu, Chuang, Lai, Qinhuai, Wu, Sijia, Fang, Aiping, Yang, Jinliang, Chen, Xiaoxin, Yao, Yuqin
Publicado en PeerJ (2019)

Design, synthesis and pharmacological evaluation of 4-(3-chloro-4-(3-cyclopropylthioureido)-2-fluorophenoxy)-7-methoxyquinoline-6-carboxamide (WXFL-152): a novel triple angiokinase...

por Yao, Yuqin, Liu, Zhuowei, Zhao, Manyu, Chen, Zhengxia, Li, Peng, Zhang, Yang, Wang, Yuxi, Zhao, Chengjian, Long, Chaofeng, Chen, Xiaoxin, Yang, Jinliang
Publicado en Acta Pharm Sin B (2020)

Discovery of the first potent proteolysis targeting chimera (PROTAC) degrader of indoleamine 2,3-dioxygenase 1

por Hu, Mingxing, Zhou, Weilin, Wang, Yijie, Yao, Dongping, Ye, Tinghong, Yao, Yuqin, Chen, Bin, Liu, Gongping, Yang, Xifei, Wang, Wei, Xie, Yongmei
Publicado en Acta Pharm Sin B (2020)

Endothelial Autophagy: an Effective Target for Radiation-induced Cerebral Capillary Damage

por Ai, Xiaolin, Ye, Zengpanpan, Yao, Yuqin, Xiao, Jianghong, You, Chao, Xu, Jianguo, Huang, Xi, Zhong, Jian, Fan, Min, Song, Xuejiao, Shi, Huashan, Zhang, Dongmei, Zhao, Chengjian
Publicado en Sci Rep (2020)

Proteomic Maps of Human Gastrointestinal Stromal Tumor Subgroups

por Liu, Yu, Li, Zhigui, Xu, Zhiqiang, Jin, Xiuxiu, Gong, Yanqiu, Xia, Xuyang, Yao, Yuqin, Xu, Zhaofen, Zhou, Yong, Xu, Heng, Li, Shuangqing, Peng, Yong, Wu, Xiaoting, Dai, Lunzhi
Publicado en Mol Cell Proteomics (2019)

Promiximab-duocarmycin, a new CD56 antibody-drug conjugates, is highly efficacious in small cell lung cancer xenograft models

por Yu, Lin, Lu, Ying, Yao, Yuqin, Liu, Yu, Wang, Yuxi, Lai, Qinhuai, Zhang, Ruirui, Li, Wenting, Wang, Ruixue, Fu, Yuyin, Tao, Yiran, Yi, Shuli, Gou, Lantu, Chen, Ligong, Yang, Jinliang
Publicado en Oncotarget (2017)

A novel multikinase inhibitor SKLB‐YTH‐60 ameliorates inflammation and fibrosis in bleomycin‐induced lung fibrosis mouse models

por Liu, Hongyao, Wu, Xiuli, Gan, Cailing, Wang, Liqun, Wang, Guan, Yue, Lin, Liu, Zhihao, Wei, Wei, Su, Xingping, Zhang, Qianyu, Tan, Zui, Yao, Yuqin, Ouyang, Liang, Yu, Luoting, Ye, Tinghong
Publicado en Cell Prolif (2021)

Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma

por Fu, Yuyin, Peng, Yujia, Zhao, Shengyan, Mou, Jun, Zeng, Lishi, Jiang, Xiaohua, Yang, Chengli, Huang, Cheng, Li, Yuyan, Lu, Yin, Wu, Mengdan, Yang, Yanfang, Kong, Ting, Lai, Qinhuai, Wu, Yangping, Yao, Yuqin, Wang, Yuxi, Gou, Lantu, Yang, Jinliang
Publicado en Front Cell Dev Biol (2021)

Therapeutic potential of an anti-HER2 single chain antibody–DM1 conjugates for the treatment of HER2-positive cancer

por Zhang, Hang, Wang, Yuxi, Wu, Yangping, Jiang, Xiaohua, Tao, Yiran, Yao, Yuqin, Peng, Yujia, Chen, Xiangzheng, Fu, Yuyin, Yu, Lin, Wang, Ruixue, Lai, Qinhuai, Lai, Weirong, Li, Wenting, Kang, Yuhuan, Yi, Shuli, Lu, Ying, Gou, Lantu, Wu, Min, Yang, Jinliang
Publicado en Signal Transduct Target Ther (2017)

A novel 5T4-targeting antibody-drug conjugate H6-DM4 exhibits potent therapeutic efficacy in gastrointestinal tumor xenograft models

por Wang, Ruixue, Lai, Qinhuai, Tang, Liangze, Tao, Yiran, Yao, Yuqin, Liu, Yu, Lu, Ying, Shen, Chaoyong, Lu, Ran, Fan, Chuanwen, Zhang, Ruirui, Wang, Yuxi, Yu, Lin, Yang, Tinghan, Wu, Yangping, Peng, Yujia, Wei, Xian, Fu, Yuyin, Lai, Weirong, Gou, Lantu, Yang, Jinliang
Publicado en Am J Cancer Res (2018)